These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12420196)

  • 1. Clinic and ambulatory pulse pressure segregate a cluster of cardiovascular risk factors.
    Ferrara LA; Guida L; Innelli P; Limauro S; Celentano A
    J Hum Hypertens; 2002 Oct; 16(10):719-24. PubMed ID: 12420196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between aortic stiffness and cardiovascular risk factors in a population of normotensives, white-coat normotensives, white-coat hypertensives, sustained hypertensives and diabetic patients.
    Silva JA; Barbosa L; Bertoquini S; Maldonado J; Polónia J
    Rev Port Cardiol; 2004 Dec; 23(12):1533-47. PubMed ID: 15732656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A; Ritz E; Viberti G; Mimran A; Rabelink AJ; Rump LC; Ruilope LM; Katayama S; Ito S; Izzo JL; Haller H
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncontrolled isolated office hypertension is associated with subclinical markers of cardiovascular disease in hypertensive type 2 diabetic patients.
    Salles GF; Teixeira GB; Leite NC; Muxfeldt ES; Cardoso CR
    Hypertens Res; 2010 Aug; 33(8):819-24. PubMed ID: 20535116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values.
    Bombelli M; Facchetti R; Carugo S; Madotto F; Arenare F; Quarti-Trevano F; Capra A; Giannattasio C; Dell'Oro R; Grassi G; Sega R; Mancia G
    J Hypertens; 2009 Dec; 27(12):2458-64. PubMed ID: 19654559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimate of white-coat effect and arterial stiffness.
    de Simone G; Schillaci G; Chinali M; Angeli F; Reboldi GP; Verdecchia P
    J Hypertens; 2007 Apr; 25(4):827-31. PubMed ID: 17351375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension.
    Stergiou GS; Argyraki KK; Moyssakis I; Mastorantonakis SE; Achimastos AD; Karamanos VG; Roussias LG
    Am J Hypertens; 2007 Jun; 20(6):616-21. PubMed ID: 17531917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse pressure and mortality in hypertensive type 2 diabetic patients. A cohort study.
    Mannucci E; Lambertucci L; Monami M; Fedeli A; Chiasserini V; Marchionni N; Masotti G; Ungar A
    Diabetes Metab Res Rev; 2006; 22(3):172-5. PubMed ID: 16270376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls.
    Svensson P; de Faire U; Niklasson U; Ostergren J
    J Hum Hypertens; 2004 Mar; 18(3):193-200. PubMed ID: 14973514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain.
    Gorostidi M; Sobrino J; Segura J; Sierra C; de la Sierra A; Hernández del Rey R; Vinyoles E; Galcerán JM; López-Eady MD; Marín R; Banegas JR; Sarría A; Coca A; Ruilope LM;
    J Hypertens; 2007 May; 25(5):977-84. PubMed ID: 17414661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes is associated with left ventricular concentric remodeling in hypertensive patients.
    Eguchi K; Kario K; Hoshide S; Ishikawa J; Morinari M; Shimada K
    Am J Hypertens; 2005 Jan; 18(1):23-9. PubMed ID: 15691613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac hypertrophy in hypertension: relation to 24-h blood pressure profile and arterial stiffness.
    Lekakis JP; Zakopoulos NA; Protogerou AD; Kotsis VT; Papaioannou TG; Stamatelopoulos KS; Tsitsiricos MD; Pitiriga VCh; Papamichael CM; Toumanides ST; Mavrikakis ME
    Int J Cardiol; 2004 Oct; 97(1):29-33. PubMed ID: 15336803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage.
    Gaborieau V; Delarche N; Gosse P
    J Hypertens; 2008 Oct; 26(10):1919-27. PubMed ID: 18806615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of ambulatory blood pressure measurements: further analyses.
    Perloff D; Sokolow M; Cowan RM; Juster RP
    J Hypertens Suppl; 1989 May; 7(3):S3-10. PubMed ID: 2527294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
    Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
    J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study.
    Hansen TW; Jeppesen J; Rasmussen S; Ibsen H; Torp-Pedersen C
    Am J Hypertens; 2006 Mar; 19(3):243-50. PubMed ID: 16500508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.